Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Toni Wall Jaudon's research focuses on long COVID, investigating its impact and potential treatment strategies. Recent publications explore the effects of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in individuals with established long COVID, presenting case series and research considerations. Jaudon also contributes to the broader discourse on long COVID research by advocating for patient-researcher collaboration and designing optimized clinical trials for the condition. Their work also touches on the role of religion in health. With an h-index of 6 and 152 total citations across 12 publications, Jaudon is actively engaged in the field, as indicated by recent activity and a shared publication with collaborator S Saniya.
Metrics
- h-index: 6
- Publications: 12
- Citations: 156
Selected Publications
-
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series (2025)
-
Designing and optimizing clinical trials for long COVID (2024)
-
Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations (2023)
Collaboration Network
Top Collaborators
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Designing and optimizing clinical trials for long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- A call from patient-researchers to advance research on long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Designing and optimizing clinical trials for long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- A call from patient-researchers to advance research on long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Designing and optimizing clinical trials for long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- A call from patient-researchers to advance research on long COVID
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
- Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- Designing and optimizing clinical trials for long COVID
- A call from patient-researchers to advance research on long COVID
- Designing and optimizing clinical trials for long COVID
- A call from patient-researchers to advance research on long COVID
Similar Researchers
Based on overlapping research topics